Despite advances in the fields of prevention, medical intervention and surgical therapy, cardiovascular disease remains a major\r\npublic healthcare issue. A promising area of research is the potential application of regenerative therapies with pluripotential\r\nstem cells to reduce the burden of heart disease and its sequelae. Umbilical cord blood, a rich source of multiple populations\r\nof nonembryonic stem cells, will be a valuable resource and has the potential to advance therapeutic options for patients with\r\nacquired and congenital heart disease.
Loading....